The supplier undertakes to deliver, from the start of the contract, only raw material from turkey produced in such a manner that antibiotics, as defined in Regulation 2019/6/EU of the European Parliament and of the Council, are not used to promote growth or routinely prevent disease. Antibiotics shall only be used on veterinary prescription for sick animals or for animals in groups where disease has broken out, after clinical disease has been diagnosed in part of the group. There shall be documentation for the raw material throughout the contract period showing the total number of medical treatments, the reason for treatment and the preparations used. Documentation per flock1 in the stable section2 where production took place will be sufficient.
A maximum of 5 per cent of the turkey raw material delivered during each 12-month period of the contract, starting from the beginning of the contract, may have been treated with antibiotics as defined in Regulation 2019/6/EU of the European Parliament and of the Council.
Third and fourth generation cephalosporins may only be used when microbiological and resistance testing shows that there is no effective alternative.
Coccidiostats as feed additives are not deemed to be antibiotics in this criterion.
1“Flock” refers to a group of animals kept together in the same stable section.
2“Stable” refers to a building for keeping animals: see Chapter 1(6) of the Swedish Board of Agriculture’s regulations and general recommendations on poultry farming in agriculture, etc. (SJVFS 2019:23). “Stable section” refers to a part of a stable that is separated from other parts of the stable, normally with dense walls.
